Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Director, 10%+ Owner
-
Stock Symbol
-
CRVS on Nasdaq
Peter A. Thompson - trading volume in the past year for Corvus Pharmaceuticals, Inc.
Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
Common Stock, $0.0001 par value |
6.94M |
$12M |
$1.73 |
Jun 13, 2024 |
Indirect |
|
|
Pre-Funded Warrants (right to buy) |
1.44M |
$2.5M |
$1.73 |
May 6, 2024 |
Indirect |
Common Stock |
|
Common Warrants (right to buy) |
1.4M |
|
|
May 6, 2024 |
Indirect |
Common Stock |
|
Stock Option (Right to Buy) |
15K |
|
|
Jun 13, 2024 |
Direct |
Common Stock |
|
Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.